180 related articles for article (PubMed ID: 16291040)
1. Central nervous system agents in the treatment of erectile dysfunction.
Kendirci M; Walls MM; Hellstrom WJ
Urol Clin North Am; 2005 Nov; 32(4):487-501, vii. PubMed ID: 16291040
[TBL] [Abstract][Full Text] [Related]
2. Centrally acting mechanisms for the treatment of male sexual dysfunction.
Miner MM; Seftel AD
Urol Clin North Am; 2007 Nov; 34(4):483-96, v. PubMed ID: 17983889
[TBL] [Abstract][Full Text] [Related]
3. Apomorphine SL (Uprima): preclinical and clinical experiences learned from the first central nervous system-acting ED drug.
Giuliano F; Allard J
Int J Impot Res; 2002 Feb; 14 Suppl 1():S53-6. PubMed ID: 11850736
[TBL] [Abstract][Full Text] [Related]
4. Future directions in erectile dysfunction therapy.
Mulhall JP
Postgrad Med; 2000 May; 107(6 Suppl Educational):19-23. PubMed ID: 19667519
[TBL] [Abstract][Full Text] [Related]
5. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
[TBL] [Abstract][Full Text] [Related]
6. Clinical applications of centrally acting agents in male sexual dysfunction.
Hellstrom WJ
Int J Impot Res; 2008 Jul; 20 Suppl 1():S17-23. PubMed ID: 18552830
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system agents and erectile dysfunction.
Kumar R; Nehra A
Urol Clin North Am; 2011 May; 38(2):165-73. PubMed ID: 21621083
[TBL] [Abstract][Full Text] [Related]
8. [Apomorphine and erectile dysfunction].
Tan DQ; Yao Y; Zhang J
Zhonghua Nan Ke Xue; 2007 Sep; 13(9):818-21. PubMed ID: 17929561
[TBL] [Abstract][Full Text] [Related]
9. Characterising the benefit of apomorphine SL (Uprima) as an optimised treatment for representative populations with erectile dysfunction.
Heaton JP
Int J Impot Res; 2001 Aug; 13 Suppl 3():S35-9. PubMed ID: 11477490
[TBL] [Abstract][Full Text] [Related]
10. Apomorphine-induced brain modulation during sexual stimulation: a new look at central phenomena related to erectile dysfunction.
Montorsi F; Perani D; Anchisi D; Salonia A; Scifo P; Rigiroli P; Zanoni M; Heaton JP; Rigatti P; Fazio F
Int J Impot Res; 2003 Jun; 15(3):203-9. PubMed ID: 12904807
[TBL] [Abstract][Full Text] [Related]
11. Examination of the safety and use of apomorphine prescribed in general practice in England as a treatment for erectile dysfunction.
Maclennan KM; Boshier A; Wilton LV; Shakir SA
BJU Int; 2006 Jul; 98(1):125-31. PubMed ID: 16831156
[TBL] [Abstract][Full Text] [Related]
12. Tolerability and safety of apomorphine SL (Ixense (TM) ).
Montorsi F
Int J Impot Res; 2003 Apr; 15 Suppl 2():S7-9. PubMed ID: 12825097
[TBL] [Abstract][Full Text] [Related]
13. Multidimensional nature of apomorphine SL (Ixense) therapy.
Costa P
Int J Impot Res; 2003 Apr; 15 Suppl 2():S13-5. PubMed ID: 12825099
[TBL] [Abstract][Full Text] [Related]
14. Anxiety and erectile dysfunction: a global approach to ED enhances results and quality of life.
Hedon F
Int J Impot Res; 2003 Apr; 15 Suppl 2():S16-9. PubMed ID: 12825100
[TBL] [Abstract][Full Text] [Related]
15. Commentary on apomorphine versus sildenafil for erectile dysfunction.
Carson CC
J Urol; 2008 May; 179(5 Suppl):S95-6. PubMed ID: 18405768
[No Abstract] [Full Text] [Related]
16. Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra).
Montorsi F; Padma-Nathan H; Glina S
Urology; 2006 Sep; 68(3 Suppl):26-37. PubMed ID: 17011373
[TBL] [Abstract][Full Text] [Related]
17. Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunction.
Afif-Abdo J; Teloken C; Damião R; Koff W; Wroclawski E; Yamasaki R; Torres LO; Sabaneeff J; Faria G; Pompeo AC; Cortado P; Glina S
BJU Int; 2008 Sep; 102(7):829-34. PubMed ID: 18537952
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
Blonde L
Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971
[TBL] [Abstract][Full Text] [Related]
19. Intranasal apomorphine. Nastech Pharmaceutical.
Kendirci M; Hellstrom WJ
IDrugs; 2004 May; 7(5):483-8. PubMed ID: 15154111
[TBL] [Abstract][Full Text] [Related]
20. New oral agents for erectile dysfunction: what is changing in our practice?
Aversa A; Fabbri A
Asian J Androl; 2001 Sep; 3(3):175-9. PubMed ID: 11561186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]